Resveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies
Nutrients · 05.08.2025 · 17 (15) · 2557
DOI: 10.3390/nu17152557 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 05.08.2025. Verfasst von Nidhi Puranik und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Resveratrol, Antioxidants, Neuroprotective Agents. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and neuronal dysfunction. It is driven by the accumulation of amyloid-beta (Aβ) plaques, Tau protein hyperphosphorylation, oxidative stress, and neuroinflammation. Resveratrol (RSV) is a natural polyphenolic compound found in grapes, berries, and red wine that has garnered attention for its potential neuroprotective properties in combating AD. The neuroprotective effects of RSV are mediated through the activation of sirtuins (SIRT1), inhibition of Aβ aggregation, modulation of Tau protein phosphorylation, and the attenuation of oxidative stress and inflammatory responses. RSV also enhances mitochondrial function and promotes autophagy, which are important processes for maintaining neuronal health. Preclinical studies have demonstrated its efficacy in reducing Aβ burden, improving cognitive performance, and mitigating synaptic damage; however, challenges such as poor bioavailability, rapid metabolism, and limited blood–brain barrier penetration restrict its clinical applicability. Recent technological advances and selected modifications are being explored to overcome these limitations and enhance its therapeutic efficacy. This review summarizes the multifaceted neuroprotective mechanisms of RSV, the synergistic potential of natural compounds in enhancing neuroprotection, and the advancements in formulation strategies aimed at mitigating AD pathology. Leveraging the therapeutic potential of natural compounds represents a compelling paradigm shift for AD management, paving the way for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea.
- Department of Botany, Career Point University, Kota 324005, Rajasthan, India.
ORCID-Profile: Nidhi Puranik, Meenakshi Kumari
Zitieren
APA
Puranik, N., Kumari, M., Tiwari, S., Dhakal, T., & Song, M. (2025). Resveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies. Nutrients, 17(15), 2557. https://doi.org/10.3390/nu17152557
Vancouver
Puranik N, Kumari M, Tiwari S, Dhakal T, Song M. Resveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies. Nutrients. 2025;17(15):2557. doi:10.3390/nu17152557
BibTeX
@article{Puranik2025,
author = {Puranik, Nidhi and Kumari, Meenakshi and Tiwari, Shraddha and Dhakal, Thakur and Song, Minseok},
title = {Resveratrol as a Therapeutic Agent in Alzheimer’s Disease: Evidence from Clinical Studies},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {15},
pages = {2557},
doi = {10.3390/nu17152557}
}
EUVIMED